If you are unable to view this newsletter, Please click here
Veticaltalk Pharma -  e-Newsletter

Industry-Academia

Interactions

September, 2011 www.pharmafocusasia.com | Archives | Advertise

Industry-Academia Interactions


How different are the industry-academia relations in India compared with the US and European countries?
In the Indian scenario, teachers are overburdened and are involved in too many non-academic activities resulting in poor research output. There are only a handful of universities and institutions with a serious focus on research.
In India, industry-academia interrelations are not very strong. Both industry and academia are not taking necessary initiatives to strengthen the relations as they do not consider this as a priority issue. On the contrary, in the US and European countries there is a strong bond between industry and academia with industry sponsoring many projects in universities and reputed institutions.


White Papers
..........................................................
media pack
..........................................................
Editorial Calender
..........................................................
News
Questcor Pharmaceuticals Announces Preliminary Operating Metrics for Third Quarter 2011
Sept. 28th, 2011
ANAHEIM, Calif.

Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced preliminary operating metrics for its third quarter ending September 30, 2011. The Company announced the estimated metrics in conjunction with the Jeffries Global Healthcare Conference in London, where Don M. Bailey, President and Chief Executive Officer of Questcor, presented on Wednesday, September 28, 2011, at 8:00 a.m. BT, 3:00 a.m. ET.
Press Releases
Synageva BioPharma Expands International Clinical Trial for Infants with Lysosomal Acid Lipase Deficiency, a Lysosomal Storage Disorder
Sep 28th, 2011
Lexington, Massachusetts

“Infants with severe LAL Deficiency (Wolman Disease) have a serious and devastating disease that is typically fatal in the first year of life. This trial is an important advancement for these patients and their families who have limited options,” said Dr. Martin Bialer, an Investigator at the North Shore LIJ Heath System in New York.
Events
Biobusiness Network
Sep 29th - Sep 30th, 2011
Geneva, Switzerland
Worldwide Business Research
sona.khagram@wbr.co.uk
Current Issue
Upcoming Issue

Mail us for
e-Book Access!

subscriptions@pharmafocusasia.com

Send to a friend | Archives | Mediapack | Advertise | Submit an Article

Support Staff : info@pharmafocusasia.com
Click here to Unsubscribe
Copyright © 2011. All Rights Reserved.